Ventyx Biosciences announces $27M investment from Sanofi
PremiumThe FlyVentyx Biosciences announces $27M investment from Sanofi
2M ago
Ventyx Biosciences announces first patient dosed in Phase 2a trial of VTX3232
Premium
The Fly
Ventyx Biosciences announces first patient dosed in Phase 2a trial of VTX3232
2M ago
Ventyx Biosciences Announces Executive Financial Officer Changes
Premium
Company Announcements
Ventyx Biosciences Announces Executive Financial Officer Changes
3M ago
Ventyx Biosciences reports Q2 EPS (45c), consensus (58c)
PremiumThe FlyVentyx Biosciences reports Q2 EPS (45c), consensus (58c)
3M ago
Ventyx falls 19% to $2.39 after Crohn’s disease trial misses endpoint
Premium
The Fly
Ventyx falls 19% to $2.39 after Crohn’s disease trial misses endpoint
4M ago
Ventyx Biosciences announces reuslts from Phase 2 trial of VTX958
Premium
The Fly
Ventyx Biosciences announces reuslts from Phase 2 trial of VTX958
4M ago
Ventyx Biosciences Names Matthew Moore New COO
PremiumCompany AnnouncementsVentyx Biosciences Names Matthew Moore New COO
6M ago
Ventyx Biosciences announces appointment of Moore as COO
Premium
The Fly
Ventyx Biosciences announces appointment of Moore as COO
6M ago
Ventyx Biosciences reports Q1 EPS (62c), consensus (67c)
Premium
The Fly
Ventyx Biosciences reports Q1 EPS (62c), consensus (67c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100